Omega Diagnostics (GB:CNSL) has released an update.
Cambridge Nutritional Sciences PLC reports a significant turnaround with a 30% revenue increase to £9.8m and a positive adjusted EBITDA of £0.2m, marking a shift from last year’s losses. The company attributes this growth to operational efficiencies, such as improved FoodPrint® production and a halved turnaround time for CNSLab, alongside a strong UK market performance. With solid cash reserves, the company is well-positioned for future growth, including investments in automation and digital applications to enhance personalized nutrition services.
For further insights into GB:CNSL stock, check out TipRanks’ Stock Analysis page.
